Acquisitions (Tables)

9 Months Ended

Sep. 30, 2022

Alfmeier

Business Acquisition [Line Items]

Summary of Product Revenues and Operating Income

The following table provides product revenues and operating income from Alfmeier that are included in our consolidated condensed financial statements:

	Three Months Ended September 30, 2022			Nine Months Ended September 30, 2022
Product revenues	$	41,281		$	41,281
Operating loss		(3,104	)		(3,104	)

Summary of Preliminary Allocation of Purchase Consideration to Estimated Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary allocation of the purchase consideration to the estimated fair values of assets acquired and liabilities assumed as of the acquisition date:

Purchase price, cash consideration, net of cash acquired	$	188,941
Purchase price, Purchase Consideration Receivable	$	(24,054	)
Total purchase price, net of cash acquired	$	164,887
Accounts receivable		24,988
Inventory		36,026
Prepaid expenses and other assets		20,920
Operating lease right-of-use assets		4,608
Property and equipment		89,942
Other intangible assets		22,668
Goodwill		43,678
Assumed liabilities		(55,994	)
Deferred tax liabilities		(21,949	)
Net assets acquired	$	164,887

Summary of Preliminary Allocation of Purchase Consideration to Other Intangible Assets Acquired

The following table summarizes the preliminary allocation of the purchase consideration to the other intangible assets acquired:

	Preliminary Fair Value		Weighted Average Life (in years)
Definite-lived:
Customer related	$	11,233		13
Technology		11,435		9
Total	$	22,668

Summary of Unaudited Pro Forma Information

The following unaudited pro forma information represents our product revenues as if the acquisition of Alfmeier had occurred as of January 1, 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Product revenues	$	352,946	$	300,520	$	1,005,337	$	992,403

Dacheng

Business Acquisition [Line Items]

Summary of Product Revenues and Operating Income

The results of Dacheng's operations are reported within the Medical segment from the date of acquisition. The following table provides product revenues and operating income from Dacheng that are included in our consolidated condensed financial statements:

	Three Months Ended September 30, 2022			Nine Months Ended September 30, 2022
Product revenues	$	1,234		$	1,234
Operating loss		(153	)		(153	)

Summary of Preliminary Allocation of Purchase Consideration to Estimated Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary allocation of the purchase consideration to the estimated fair values of assets acquired and liabilities assumed as of the acquisition date:

Purchase price, cash consideration, net of cash acquired	$	35,048
Accounts receivable		746
Inventory		1,942
Prepaid expenses and other assets		152
Operating lease right-of-use assets		841
Property and equipment		684
Other intangible assets		19,094
Goodwill		22,995
Assumed liabilities		(2,799	)
Deferred tax liabilities		(8,607	)
Net assets acquired	$	35,048

Summary of Preliminary Allocation of Purchase Consideration to Other Intangible Assets Acquired

The following table summarizes the preliminary allocation of the purchase consideration to the other intangible assets acquired:

	Preliminary Fair Value		Weighted Average Life (in years)
Definite-lived:
Customer related	$	11,873		12
Technology		4,749		12
Indefinite-lived:
Tradenames		2,472		—
Total	$	19,094